An analysis of genetic heterogeneity in untreated cancers

JG Reiter, M Baretti, JM Gerold… - Nature Reviews …, 2019 - nature.com
Genetic intratumoural heterogeneity is a natural consequence of imperfect DNA replication.
Any two randomly selected cells, whether normal or cancerous, are therefore genetically …

Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening

R Esposito, N Bosch, A Lanzós, T Polidori… - Cancer cell, 2019 - cell.com
Long non-coding RNAs (lncRNAs) represent a huge reservoir of potential cancer targets.
Such" onco-lncRNAs" have resisted traditional RNAi methods, but CRISPR-Cas9 genome …

Discovery of common and rare genetic risk variants for colorectal cancer

JR Huyghe, SA Bien, TA Harrison, HM Kang, S Chen… - Nature …, 2019 - nature.com
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-
genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence …

Identification of cancer driver genes based on nucleotide context

F Dietlein, D Weghorn, A Taylor-Weiner, A Richters… - Nature …, 2020 - nature.com
Cancer genomes contain large numbers of somatic mutations but few of these mutations
drive tumor development. Current approaches either identify driver genes on the basis of …

A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies

A Degasperi, TD Amarante, J Czarnecki, S Shooter… - Nature cancer, 2020 - nature.com
Mutational signatures are patterns of mutations that arise during tumorigenesis. We present
an enhanced, practical framework for mutational signature analyses. Applying these …

The U1 spliceosomal RNA is recurrently mutated in multiple cancers

S Shuai, H Suzuki, A Diaz-Navarro, F Nadeu… - Nature, 2019 - nature.com
Cancers are caused by genomic alterations known as drivers. Hundreds of drivers in coding
genes are known but, to date, only a handful of noncoding drivers have been discovered …

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic

AM Frankell, SG Jammula, X Li, G Contino… - Nature …, 2019 - nature.com
Esophageal adenocarcinoma (EAC) is a poor-prognosis cancer type with rapidly rising
incidence. Understanding of the genetic events driving EAC development is limited, and …

A pan-cancer transcriptome analysis reveals pervasive regulation through alternative promoters

D Demircioğlu, E Cukuroglu, M Kindermans, T Nandi… - Cell, 2019 - cell.com
Most human protein-coding genes are regulated by multiple, distinct promoters, suggesting
that the choice of promoter is as important as its level of transcriptional activity. However …

[HTML][HTML] Local determinants of the mutational landscape of the human genome

A Gonzalez-Perez, R Sabarinathan, N Lopez-Bigas - Cell, 2019 - cell.com
Large-scale chromatin features, such as replication time and accessibility influence the rate
of somatic and germline mutations at the megabase scale. This article reviews how local …

An integrative ENCODE resource for cancer genomics

J Zhang, D Lee, V Dhiman, P Jiang, J Xu… - Nature …, 2020 - nature.com
ENCODE comprises thousands of functional genomics datasets, and the encyclopedia
covers hundreds of cell types, providing a universal annotation for genome interpretation …